Hoth Therapeutics, Inc. - ROE
RKTO
Price:
$0.7957
Market Cap:
$17.76M
Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure. It also develops AI chip and memory hardware engineered for orbital and high-radiation environments, including next generation nanomagnetic AI chip technology. It offers semiconductor infrastructure built around nanomagnetic, and spintronic computing technologies designed to address these constraints at the hardware level. It also offers non-volatile nanomagnetic matrix multiplier architecture for machine learning and AI acceleration and spintronic memory technology with potential applications across defense systems, autonomous platforms, resilient edge compute, and radiation-tolerant space computing. ...[Read more]
Industry
Software - Infrastructure
IPO Date
2019-02-15
Stock Exchange
NASDAQ Global Market
Ticker
RKTO
PE Ratio
[-0.88]
ROE
[-199.23%]
Current Ratio
[6.20]
Dividend Yield
[0%]
Enterprise Value
[9.87M]
Dividend History
The ROE as of September 2026 (TTM) for Hoth Therapeutics, Inc. (RKTO) is -199.23%
According to Hoth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -199.23%. This represents a change of 288.66% compared to the average of -51.26% of the last 4 quarters.
Hoth Therapeutics, Inc. (RKTO) Historical ROE (quarterly & annually)
How has RKTO ROE performed in the past?
The mean historical ROE of Hoth Therapeutics, Inc. over the last ten years is -336.39%. The current -199.23% ROE has changed -40.77% with respect to the historical average. Over the past ten years (40 quarters), RKTO's ROE was at its highest in in the June 2017 quarter at 0%. The ROE was at its lowest in in the December 2018 quarter at -309.78%.
Average
-336.39%
Median
-170.16%
Minimum
-1610.38%
Maximum
-82.25%
Hoth Therapeutics, Inc. (RKTO) ROE by Quarter and Year
Discovering the peaks and valleys of Hoth Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 846.39%
Maximum Annual ROE = -82.25%
Minimum Annual Increase = -80.06%
Minimum Annual ROE = -1610.38%
| Year | ROE | Change |
|---|---|---|
| 2025 | -202.73% | 70.31% |
| 2024 | -119.04% | 44.72% |
| 2023 | -82.25% | -62.96% |
| 2022 | -222.04% | 53.30% |
| 2021 | -144.84% | -6.52% |
| 2020 | -154.94% | -51.75% |
| 2019 | -321.13% | -80.06% |
| 2018 | -1610.38% | 846.39% |
Hoth Therapeutics, Inc. (RKTO) Average ROE
How has RKTO ROE performed in the past?
The current ROE of Hoth Therapeutics, Inc. (RKTO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-134.67%
5-year avg
-154.18%
10-year avg
-336.39%
Hoth Therapeutics, Inc. (RKTO) ROE vs. Peers
How is RKTO’s ROE compared to its peers?
Hoth Therapeutics, Inc.’s ROE is greater than Curis, Inc. (-1035.26%), greater than BriaCell Therapeutics Corp. (-147.92%), greater than Palisade Bio, Inc. (-33.47%), greater than Processa Pharmaceuticals, Inc. (-394.24%), less than Aspire Biopharma Holdings, Inc. (1.99%), greater than Lexaria Bioscience Corp. (-160.72%), greater than FibroBiologics, Inc. Common Stock (-536.78%), greater than Pulmatrix, Inc. (-109.26%), greater than Dare Bioscience, Inc. (-748.08%), greater than Entero Therapeutics, Inc. (-55.12%),
| Company | ROE | Market cap |
|---|---|---|
| -1035.26% | $2.12M | |
| -147.92% | $36.71M | |
| -33.47% | $295.09M | |
| -394.24% | $5.26M | |
| 1.99% | $1.05M | |
| -160.72% | $5.44M | |
| -536.78% | $3.11M | |
| -109.26% | $5.23M | |
| -748.08% | $11.20M | |
| -55.12% | $13.58M |
Build a custom stock screener for Hoth Therapeutics, Inc. (RKTO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hoth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hoth Therapeutics, Inc. (RKTO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hoth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Hoth Therapeutics, Inc.'s ROE?
How is the ROE calculated for Hoth Therapeutics, Inc. (RKTO)?
What is the highest ROE for Hoth Therapeutics, Inc. (RKTO)?
What is the 3-year average ROE for Hoth Therapeutics, Inc. (RKTO)?
What is the 5-year average ROE for Hoth Therapeutics, Inc. (RKTO)?
How does the current ROE for Hoth Therapeutics, Inc. (RKTO) compare to its historical average?